# Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice

> **NCT00564187** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 115 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Irbesartan
- **DRUG:** Irbesartan

## Key facts

- **NCT ID:** NCT00564187
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2007-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00564187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00564187, "Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00564187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*